VIDEOSGZERO World with Ian BremmerQuick TakePUPPET REGIMEIan ExplainsGZERO ReportsAsk IanGlobal Stage
Site Navigation
Search
Human content,
AI powered search.
Latest Stories
Start your day right!
Get latest updates and insights delivered to your inbox.
GZERO Live
Explore GZERO’s past virtual conversations, featuring global experts on the world's urgent issues.
Presented by
Almost one year since the coronavirus upended the world, what's the current state of play on ending the pandemic, and what challenges we face towards vaccinating everyone in 2021.
Fortunately, as the virus has grown exponentially, so has science, Dr. Larry Brilliant, CEO of Pandefense and one of the world's most highly regarded epidemiologists, said during the panel discussion on fighting COVID-19 at the 2020 GZERO Summit in Japan.
Science, he explained, has accomplished the audacity of developing successful vaccines in record time. That's why he's optimistic about ending the pandemic next year in many parts of the world, even if the next 2-3 months will be very bad mainly in Western countries.
Part of the reason for his optimism is the great news about the efficacy of vaccines like the one developed by US pharmaceutical giant Pfizer and German company BioNTech, which the UK started administering to its citizens on Tuesday.
For Angela Hwang, president of Pfizer's biopharmaceuticals group, developing the vaccine is just the start. Now enough people need to get vaccinated to achieve the herd immunity necessary to stop the virus in its tracks.
To build sufficient trust in the drug to achieve that goal, she said, everyone needs to be on board. It'll take not only the private and public sectors working together but all of society committed to making everyone understand that vaccines work, and that you must get inoculated at a moment of extreme resistance in some countries.
Also, mass vaccination means it must happen across the developing world at the same level as in developing countries. The world is just too interconnected to leave anyone behind, noted Gargee Ghosh, president for global advocacy and programs at the Bill and Melinda Gates Foundation.
Even where many people are suspicious of vaccines, she added, ultimately the clear benefits of restarting economies will hopefully convince those who fear rolling up their arms.
Vaccinations likely won't be a problem in Japan, where Yasutoshi Nishimura, minister, in charge of economic revitalization, underscored how the majority of the population has heeded their advice to practice social distance, wear masks, stay at home and shut down businesses despite no mandatory orders to do so.
Watch the above video to learn more insights from our panelists.
Keep reading...Show less
More from GZERO Live
Ian Bremmer: Trump is a symptom of a dysfunctional "G-Zero world"
January 15, 2025
Top Risks 2025: America's role in the crumbling global order
January 09, 2025
Unpacking the biggest global threats of 2025
January 08, 2025
Ian Bremmer explains the 10 Top Risks of 2025
January 07, 2025
What would a second Trump term mean? Think Jurassic Park
January 10, 2024
The global water crisis and the path to a sustainable future
November 29, 2023
Can the world learn lessons from vaccine inequity?
March 02, 2022
Corporations losing the culture wars — Angela Hofmann
January 14, 2022
China’s pandemic playbook will fail with Omicron — Laura Yasaitis
January 09, 2022
Cliff Kupchan: We need a national dialogue to save US democracy
January 05, 2022
Ian Bremmer: Zero COVID no longer works, and China will pay a price
January 04, 2022
Indonesia's tricky balance on climate and poverty
October 29, 2021
How US foreign policy impacts all Americans
June 15, 2021
GZERO Summit on sustainability: COVID-19’s promise on ESG
December 11, 2020
GZERO Summit on geotech: US-China tech Cold War or “stable tension”?
December 10, 2020
GZERO Summit: Geopolitics in a post-pandemic world
December 09, 2020
GZERO Series
GZERO Daily: our free newsletter about global politics
Keep up with what’s going on around the world - and why it matters.



























